Study Title
APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening Trial – Developing New Therapies for Relapsed Leukemias
Protocol ID
APAL2020SC
Condition/s
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Myeloid Leukemia Post Cytotoxic Therapy
Juvenile Myelomonocytic Leukemia
Mixed Phenotype Acute Leukemia
Myelodysplastic Syndrome
Myelodysplastic Syndrome Post Cytotoxic Therapy
Myeloid Leukemia Associated With Down Syndrome
Acute Myeloid Leukemia
Acute Myeloid Leukemia Post Cytotoxic Therapy
Juvenile Myelomonocytic Leukemia
Mixed Phenotype Acute Leukemia
Myelodysplastic Syndrome
Myelodysplastic Syndrome Post Cytotoxic Therapy
Myeloid Leukemia Associated With Down Syndrome
Diagnosis Stage
Relapsed/refractory
Location
NSW, QLD, VIC, WA, NZ
Sponsor
LLS PedAL Initiative, LLC
Collaborators
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Christchurch Hospital
Royal Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Starship Hospital
Christchurch Hospital
Royal Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Starship Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 22 Years
International registry ID's
NCT04726241
| Study Title | APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening Trial – Developing New Therapies for Relapsed Leukemias |
|---|---|
| Protocol ID | APAL2020SC |
| Disease (Sub Disease) | Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Post Cytotoxic Therapy Juvenile Myelomonocytic Leukemia Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome Myelodysplastic Syndrome Post Cytotoxic Therapy Myeloid Leukemia Associated With Down Syndrome |
| Diagnosis Stage | Relapsed/refractory |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | LLS PedAL Initiative, LLC |
| Collaborators | Children's Oncology Group/ National Cancer Institute (NCI)/ |
| Links | https://clinicaltrials.gov/ct2/show/NCT04726241 |
| Trial Status | Open |
| Trial Open Date | 30/11/2021 |
| Sites | The Children's Hospital at Westmead / Christchurch Hospital / Royal Children's Hospital / Queensland Children's Hospital / Perth Children's Hospital/ Starship Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | up to 22 Years |
| International registry ID's | NCT04726241 |